Trittico Prolong 300 mg in the treatment of depression

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/28262
• EU PAS number:
  EUPAS19469
• Study ID:
  28262
• Official title and acronym:
  Trittico Prolong 300 mg in the treatment of depression
• DARWIN EU® study:
  No
• Study countries:
  Czechia
• Study status:
  Finalised

Research institutions and networks

Institutions

Angelini Pharma

Multiple centres: 8 centres are involved in the study

Study timelines

Date when funding contract was signed

Actual: 01/07/2015

Study start date

Actual: 08/07/2015

Date of final study report

Actual: 30/06/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Angelini Pharma Česká republika s.r.o.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

CZ SIDC number 1505070002